Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2015-03-02 08:00 |
Karolinska Development confirms full payment in the rights issue of convertibles
|
English | 273.0 KB | ||
| 2015-02-19 08:00 |
Dilaforette ingår samarbete med Ergomed för utveckling av behandling inom sickl…
|
Swedish | 320.6 KB | ||
| 2015-02-19 08:00 |
Dilaforette Announces Co-Development Agreement with Ergomed for Sickle-Cell Dis…
|
English | 328.9 KB | ||
| 2015-02-18 08:00 | Swedish | 644.3 KB | |||
| 2015-02-18 08:00 | English | 667.0 KB | |||
| 2015-01-28 17:45 |
CEO Bruno Lucidi leaves Karolinska Development and Deputy CEO Terje Kalland is …
|
English | 275.3 KB | ||
| 2015-01-28 17:45 |
VD Bruno Lucidi lämnar Karolinska Development och vice VD Terje Kalland utses t…
|
Swedish | 273.2 KB | ||
| 2015-01-16 08:00 |
Update of Karolinska Development rights issue outcome
|
English | 291.7 KB | ||
| 2015-01-16 08:00 |
Uppdatering avseende Karolinska Developments konvertibelemission
|
Swedish | 293.9 KB | ||
| 2014-12-30 18:58 |
Karolinska Development offentliggör utfallet i företrädesemissionen av konverti…
|
Swedish | 308.5 KB | ||
| 2014-12-30 18:58 |
Karolinska Development announces outcome of the rights issue of convertibles
|
English | 307.5 KB | ||
| 2014-12-15 10:18 | English | 33.6 KB | |||
| 2014-12-08 08:15 |
Purchase of own shares to cover social security fees related to incentive progr…
|
English | 274.2 KB | ||
| 2014-12-08 08:15 |
Återköp av egna aktier för att täcka sociala avgifter kopplade till incitaments…
|
Swedish | 276.7 KB | ||
| 2014-12-05 13:37 |
Prospekt avseende inbjudan till teckning av konvertibler i Karolinska Developme…
|
Swedish | 290.0 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
